Organon (OGN) Revenue & Revenue Breakdown
Organon Revenue Highlights
Latest Revenue (Y)
$6.22B
Latest Revenue (Q)
$1.46B
Main Geography (Y)
Non-US
Organon Revenue by Period
Organon Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $6.22B | -2.92% |
| 2024-12-31 | $6.40B | 2.24% |
| 2023-12-31 | $6.26B | 1.44% |
| 2022-12-31 | $6.17B | -2.06% |
| 2021-12-31 | $6.30B | -3.49% |
| 2020-12-31 | $6.53B | -16.01% |
| 2019-12-31 | $7.78B | -20.46% |
| 2018-12-31 | $9.78B | -6.89% |
| 2017-12-31 | $10.50B | - |
Organon generated $6.22B in revenue during NA 2025, up -2.92% compared to the previous quarter, and up 95.16% compared to the same period a year ago.
Organon Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $1.46B | -3.12% |
| 2025-12-31 | $1.51B | -5.93% |
| 2025-09-30 | $1.60B | 0.50% |
| 2025-06-30 | $1.59B | 5.35% |
| 2025-03-31 | $1.51B | -4.96% |
| 2024-12-31 | $1.59B | 0.63% |
| 2024-09-30 | $1.58B | -1.56% |
| 2024-06-30 | $1.61B | -0.92% |
| 2024-03-31 | $1.62B | 1.50% |
| 2023-12-31 | $1.60B | 5.20% |
| 2023-09-30 | $1.52B | -5.53% |
| 2023-06-30 | $1.61B | 4.55% |
| 2023-03-31 | $1.54B | 3.57% |
| 2022-12-31 | $1.49B | -3.38% |
| 2022-09-30 | $1.54B | -3.03% |
| 2022-06-30 | $1.58B | 1.15% |
| 2022-03-31 | $1.57B | -2.25% |
| 2021-12-31 | $1.60B | 0.19% |
| 2021-09-30 | $1.60B | -1.11% |
| 2021-06-30 | $1.62B | 7.44% |
| 2021-03-31 | $1.51B | -6.63% |
| 2020-12-31 | $1.61B | - |
| 2020-09-30 | $1.61B | 5.70% |
| 2020-06-30 | $1.53B | -14.27% |
| 2020-03-31 | $1.78B | - |
Organon generated $1.46B in revenue during Q1 2026, up -3.12% compared to the previous quarter, and up 91.71% compared to the same period a year ago.
Organon Revenue Breakdown
Organon Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Other Countries | $93.00M | $137.00M | $154.00M | $151.00M | $233.00M |
| Non-US | $4.61B | - | - | - | - |
| Latin America, Middle East, Russia And Africa | $1.07B | $1.03B | - | - | - |
| Asia Pacific and Japan | $1.00B | $1.05B | $1.13B | $1.14B | $1.17B |
| CHINA | $829.00M | $847.00M | $864.00M | $917.00M | $933.00M |
| Europe And Canada | $1.62B | $1.76B | - | - | - |
| UNITED STATES | $1.60B | $1.57B | $1.48B | - | - |
| Latin America, Middle East, Russia and Africa | - | - | $965.00M | $895.00M | $841.00M |
| Europe and Canada | - | - | $1.67B | $1.63B | $1.74B |
Organon's latest annual revenue breakdown by geography, as of Dec 25: Non-US (42.59%), Europe And Canada (14.94%), UNITED STATES (14.81%), Latin America, Middle East, Russia And Africa (9.90%), Asia Pacific and Japan (9.24%), CHINA (7.66%), and Other Countries (0.86%).
Quarterly Revenue by Country
| Country | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Latin America, Middle East, Russia And Africa | $247.00M | $261.00M | $286.00M | $285.00M | $240.00M | $791.00M | $243.00M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Countries | $23.00M | $18.00M | $23.00M | $22.00M | $30.00M | $70.00M | $33.00M | $34.00M | $32.00M | $32.00M | $41.00M | $49.00M | $22.00M | $48.00M | $40.00M | $43.00M | $43.00M | $67.00M | $51.00M | $-28.00M |
| UNITED STATES | $358.00M | $372.00M | $406.00M | $414.00M | $412.00M | $803.00M | $398.00M | $371.00M | $1.11B | $370.00M | - | - | - | - | - | - | - | - | - | - |
| Asia Pacific and Japan | $226.00M | $248.00M | $251.00M | $250.00M | $251.00M | $503.00M | $260.00M | $287.00M | $260.00M | $284.00M | $261.00M | $324.00M | $255.00M | $283.00M | $291.00M | $314.00M | $299.00M | $287.00M | $309.00M | $285.00M |
| CHINA | $194.00M | $202.00M | $219.00M | $204.00M | $204.00M | $429.00M | $212.00M | $206.00M | $203.00M | $202.00M | $234.00M | $225.00M | $196.00M | $241.00M | $244.00M | $236.00M | $240.00M | $252.00M | $236.00M | $205.00M |
| Europe And Canada | $412.00M | $406.00M | $417.00M | $419.00M | $376.00M | $1.33B | $436.00M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-US | $1.10B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Latin America, Middle East, Russia and Africa | - | - | - | - | - | - | - | $274.00M | $278.00M | $239.00M | $234.00M | $214.00M | $230.00M | $236.00M | $216.00M | $209.00M | $246.00M | $238.00M | $190.00M | $203.00M |
| Europe and Canada | - | - | - | - | - | - | - | $450.00M | $414.00M | $392.00M | $467.00M | $400.00M | $388.00M | $363.00M | $443.00M | $436.00M | $427.00M | $410.00M | $470.00M | $490.00M |
Organon's latest quarterly revenue breakdown by geography, as of Mar 26: Non-US (43.01%), Europe And Canada (16.08%), UNITED STATES (13.97%), Latin America, Middle East, Russia And Africa (9.64%), Asia Pacific and Japan (8.82%), CHINA (7.57%), and Other Countries (0.90%).
Organon Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| OGN | Organon | $6.22B | $1.46B |
| SEM | Select Medical | $5.45B | $1.42B |
| MD | Pediatrix Medical Group | $1.91B | $476.20M |
| GRDN | Guardian Pharmacy Services | $1.45B | $377.43M |
| PAHC | Phibro Animal Health | $1.30B | $373.91M |
| HRMY | Harmony Biosciences | $868.45M | $215.39M |
| TLRY | Tilray Brands | $821.31M | $206.73M |
| AUPH | Aurinia Pharmaceuticals | $283.06M | $77.70M |
| AVDL | Avadel Pharmaceuticals | $169.12M | $77.47M |
| ALVO | Alvotech | $91.43M | $12.43M |
| NUVB | Nuvation Bio | $62.90M | $83.23M |